Regeneron Pharmaceuticals, Inc. Portfolio Stock Holdings

According to the SEC 13F filed on August 7, 2026, Regeneron Pharmaceuticals, Inc. disclosed 3 stock positions valued at approximately $177.22M as of quarter-end June 30, 2026. The largest holdings include Parabilis Medicines, Inc., Intellia Therapeutics, Inc., and Adicet Bio, Inc..

Report Period
June 30, 2026
No. of Stocks
3
Portfolio Value
$177.22M
Holdings by Sector
Regeneron Pharmaceuticals, Inc. Portfolio Holdings in Q2 2026
CompanySymbolSectorPortfolio %SharesChange (Shares)Change %Value
Parabilis Medicines, Inc.PBLSHealthcare64.35%4,166,666+4,166,666+100.00%$114,041,648
Intellia Therapeutics, Inc.NTLAHealthcare35.35%3,702,995--$62,654,675
Adicet Bio, Inc.ACETHealthcare0.30%60,511--$522,819
Showing 3 of 3 holdings in the latest reporting period.